Checchi Capital Advisers, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1598186
BEVERLY HILLS, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,243,059
-$224,646 QoQ
Shares Held
9,839
-6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#986
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2020CallValue
$191,265,984
CallShares
2,558,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. GILD ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
9,839 | $1,243,059 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,243,059 | 9,839 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,467,705 | 10,531 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,144,795 | 9,327 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,035,408 | 9,328 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,133,424 | 10,223 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,244,763 | 11,109 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $975,889 | 10,565 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $860,869 | 10,268 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $698,518 | 10,181 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $845,231 | 11,539 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $919,139 | 11,346 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $837,154 | 11,171 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $895,245 | 11,616 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $894,416 | 10,780 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $875,069 | 10,193 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $666,683 | 10,807 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $660,934 | 10,693 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $490,938 | 8,258 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $548,423 | 7,553 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $537,356 | 7,693 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $567,888 | 8,247 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $492,545 | 7,621 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $386,671 | 6,637 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $583,243 | 9,230 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $949,208 | 12,337 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $899,512 | 12,032 | Shares | Sole | 2020-05-07 | |
| 2020-03-31 | $191,265,984 | 2,558,400 | Call | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||